{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T16:02:32Z","timestamp":1792252952129,"version":"4.4.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"DOI":"10.1007\/s10753-025-02340-2","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T01:44:12Z","timestamp":1754531052000},"page":"4475-4491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Membrane-Associated RING-CH-Type Finger 6 Protects against Hypertension-Induced Cardiac Remodeling by Suppressing Cardiomyocyte Ferroptosis Through the Degradation of ACSL4"],"prefix":"10.1007","volume":"48","author":[{"given":"Rui","family":"Hao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changhu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianghua","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"2340_CR1","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1161\/CIRCULATIONAHA.108.845792","volume":"123","author":"MH Drazner","year":"2011","unstructured":"Drazner, M. H. 2011. The progression of hypertensive heart disease. Circulation 123:327\u2013334.","journal-title":"Circulation"},{"key":"2340_CR2","doi-asserted-by":"publisher","first-page":"e347","DOI":"10.1161\/CIR.0000000000001209","volume":"149","author":"SS Martin","year":"2024","unstructured":"Martin, S. S., A. W. Aday, Z. I. Almarzooq, C. A. M. Anderson, P. Arora, C. L. Avery, C. M. Baker-Smith, B. Barone Gibbs, A. Z. Beaton, and A. K. Boehme et al. 2024. 2024 heart disease and stroke statistics: A report of US and global data from the American heart association. Circulation 149:e347\u2013e913.","journal-title":"Circulation"},{"key":"2340_CR3","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","volume":"16","author":"KT Mills","year":"2020","unstructured":"Mills, K. T., A. Stefanescu, and J. He. 2020. The global epidemiology of hypertension. Nature Reviews Nephrology 16:223\u2013237.","journal-title":"Nature Reviews Nephrology"},{"key":"2340_CR4","doi-asserted-by":"publisher","first-page":"102805","DOI":"10.1016\/j.cpcardiol.2024.102805","volume":"49","author":"SN Khalid","year":"2024","unstructured":"Khalid, S. N., T. Mansoor, M. I. Bilal, S. H. Ijaz, M. Fudim, S. J. Greene, V. Nambi, S. S. Virani, G. C. Fonarow, and D. Abramov et al. 2024. Ongoing and future clinical trials of device therapies for patients with heart failure. Current Problems in Cardiology 49:102805.","journal-title":"Current Problems in Cardiology"},{"key":"2340_CR5","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1007\/s11886-024-02112-8","volume":"26","author":"M Ketabi","year":"2024","unstructured":"Ketabi, M., Z. Mohammadi, Z. Fereidouni, O. Keshavarzian, Z. Karimimoghadam, F. Sarvi, R. Tabrizi, and M. Khodadost. 2024. The effect of recurrent heart failure hospitalizations on the risk of cardiovascular and all-Cause mortality: A systematic review and Meta-Analysis. Current Cardiology Reports 26:1113\u20131122.","journal-title":"Current Cardiology Reports"},{"key":"2340_CR6","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1038\/s41569-024-01046-6","volume":"21","author":"MS Khan","year":"2024","unstructured":"Khan, M.S., I. Shahid, A. Bennis, A. Rakisheva, M. Metra, and J. Butler. 2024. Global epidemiology of heart failure. Nature Reviews Cardiology 21: 717\u2013734.","journal-title":"Nature Reviews Cardiology"},{"key":"2340_CR7","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1097\/HJH.0000000000003774","volume":"42","author":"DB Dordevic","year":"2024","unstructured":"Dordevic, D. B., G. P. Koracevic, A. D. Dordevic, and D. B. Lovic. 2024. Hypertension and left ventricular hypertrophy. Journal of Hypertension 42:1505\u20131515.","journal-title":"Journal of Hypertension"},{"key":"2340_CR8","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1093\/jb\/mvae031","volume":"176","author":"M Nishida","year":"2024","unstructured":"Nishida, M., X. Mi, Y. Ishii, Y. Kato, and A. Nishimura. 2024. Cardiac remodeling: Novel pathophysiological mechanisms and therapeutic strategies. J Biochem 176:255\u2013262.","journal-title":"J Biochem"},{"key":"2340_CR9","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1152\/physrev.00022.2018","volume":"99","author":"DP Del Re","year":"2019","unstructured":"Del Re, D. P., D. Amgalan, A. Linkermann, Q. Liu, and R. N. Kitsis. 2019. Fundamental mechanisms of regulated cell death and implications for heart disease. Physiological Reviews 99:1765\u20131817.","journal-title":"Physiological Reviews"},{"key":"2340_CR10","doi-asserted-by":"publisher","first-page":"166297","DOI":"10.1016\/j.bbadis.2021.166297","volume":"1868","author":"MD Martens","year":"2022","unstructured":"Martens, M. D., J. Karch, and J. W. Gordon. 2022. The molecular mosaic of regulated cell death in the cardiovascular system. Biochim Biophys Acta Mol Basis Dis 1868:166297.","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2340_CR11","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.tcb.2023.06.002","volume":"34","author":"S Ahola","year":"2024","unstructured":"Ahola, S., and T. Langer. 2024. Ferroptosis in mitochondrial cardiomyopathy. Trends in Cell Biology 34:150\u2013160.","journal-title":"Trends in Cell Biology"},{"key":"2340_CR12","doi-asserted-by":"publisher","first-page":"612","DOI":"10.7150\/ijms.88476","volume":"21","author":"Z Song","year":"2024","unstructured":"Song, Z., J. Wang, and L. Zhang. 2024. Ferroptosis: A new mechanism in diabetic cardiomyopathy. International Journal of Medical Sciences 21:612\u2013622.","journal-title":"International Journal of Medical Sciences"},{"key":"2340_CR13","doi-asserted-by":"publisher","first-page":"1146651","DOI":"10.3389\/fphar.2023.1146651","volume":"14","author":"H Sun","year":"2023","unstructured":"Sun, H., D. Chen, W. Xin, L. Ren, Q. Li, and X. Han. 2023. Targeting ferroptosis as a promising therapeutic strategy to treat cardiomyopathy. Frontiers in Pharmacology 14:1146651.","journal-title":"Frontiers in Pharmacology"},{"key":"2340_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.1038\/s41580-020-00324-8","volume":"22","author":"X Jiang","year":"2021","unstructured":"Jiang, X., B. R. Stockwell, and M. Conrad. 2021. Ferroptosis: Mechanisms, biology and role in disease. Nature Reviews Molecular Cell Biology 22:266\u2013282.","journal-title":"Nature Reviews Molecular Cell Biology"},{"key":"2340_CR15","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1007\/s10565-022-09778-2","volume":"39","author":"Y Lv","year":"2023","unstructured":"Lv, Y., M. Wu, Z. Wang, and J. Wang. 2023. Ferroptosis: From regulation of lipid peroxidation to the treatment of diseases. Cell Biology and Toxicology 39:827\u2013851.","journal-title":"Cell Biology and Toxicology"},{"key":"2340_CR16","doi-asserted-by":"publisher","first-page":"2521","DOI":"10.1097\/CM9.0000000000002533","volume":"136","author":"K Ding","year":"2023","unstructured":"Ding, K., C. Liu, L. Li, M. Yang, N. Jiang, S. Luo, and L. Sun. 2023. Acyl-CoA synthase ACSL4: An essential target in ferroptosis And fatty acid metabolism. Chin Med J (Engl) 136:2521\u20132537.","journal-title":"Chin Med J (Engl)"},{"key":"2340_CR17","doi-asserted-by":"publisher","first-page":"10021","DOI":"10.3390\/ijms241210021","volume":"24","author":"B Jia","year":"2023","unstructured":"Jia, B., J. Li, Y. Song, and C. Luo. 2023. ACSL4-Mediated ferroptosis and its potential role in central nervous system diseases and injuries. International Journal of Molecular Sciences 24:10021.","journal-title":"International Journal of Molecular Sciences"},{"key":"2340_CR18","doi-asserted-by":"publisher","first-page":"116548","DOI":"10.1016\/j.ejmech.2024.116548","volume":"274","author":"B Li","year":"2024","unstructured":"Li, B., K. Cheng, T. Wang, X. Peng, P. Xu, G. Liu, D. Xue, N. Jiao, and C. Wang. 2024. Research progress on GPX4 targeted compounds. European Journal of Medicinal Chemistry 274:116548.","journal-title":"European Journal of Medicinal Chemistry"},{"key":"2340_CR19","doi-asserted-by":"publisher","first-page":"111065","DOI":"10.1016\/j.brainresbull.2024.111065","volume":"217","author":"C Wei","year":"2024","unstructured":"Wei, C. 2024. The role of glutathione peroxidase 4 in neuronal ferroptosis and its therapeutic potential in ischemic and hemorrhagic stroke. Brain Research Bulletin 217:111065.","journal-title":"Brain Research Bulletin"},{"key":"2340_CR20","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.yjmcc.2022.10.004","volume":"173","author":"X Yang","year":"2022","unstructured":"Yang, X., N. K. Kawasaki, J. Min, T. Matsui, and F. Wang. 2022. Ferroptosis in heart failure. Journal of Molecular and Cellular Cardiology 173:141\u2013153.","journal-title":"Journal of Molecular and Cellular Cardiology"},{"key":"2340_CR21","doi-asserted-by":"publisher","first-page":"115765","DOI":"10.1016\/j.biopha.2023.115765","volume":"168","author":"K Zhang","year":"2023","unstructured":"Zhang, K., X. M. Tian, W. Li, and L. Y. Hao. 2023. Ferroptosis in cardiac hypertrophy and heart failure. Biomedicine & Pharmacotherapy 168:115765.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"2340_CR22","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/s41392-024-01962-6","volume":"9","author":"X Bi","year":"2024","unstructured":"Bi, X., X. Wu, J. Chen, X. Li, Y. Lin, Y. Yu, X. Fang, X. Cheng, Z. Cai, and T. Jin et al. 2024. Characterization of ferroptosis-triggered pyroptotic signaling in heart failure. Signal Transduct Target Ther 9:257.","journal-title":"Signal Transduct Target Ther"},{"key":"2340_CR23","doi-asserted-by":"publisher","first-page":"e2400073","DOI":"10.1002\/bies.202400073","volume":"46","author":"NM Fenton","year":"2024","unstructured":"Fenton, N. M., L. Qian, E. G. Paine, L. J. Sharpe, and A. J. Brown. 2024. A paredox in the control of cholesterol biosynthesis: Does the NADPH sensor and E3 ubiquitin ligase MARCHF6 protect mammalian cells during oxidative stress by controlling sterol biosynthesis? Bioessays 46:e2400073.","journal-title":"Bioessays"},{"key":"2340_CR24","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1126\/science.aaa3844","volume":"347","author":"SE Park","year":"2015","unstructured":"Park, S. E., J. M. Kim, O. H. Seok, H. Cho, B. Wadas, S. Y. Kim, A. Varshavsky, and C. S. Hwang. 2015. Control of mammalian G protein signaling by N-terminal acetylation and the N-end rule pathway. Science 347:1249\u20131252.","journal-title":"Science"},{"key":"2340_CR25","doi-asserted-by":"publisher","first-page":"2182","DOI":"10.1038\/s41467-024-46409-2","volume":"15","author":"K Wu","year":"2024","unstructured":"Wu, K., S. Itskanov, D. L. Lynch, Y. Chen, A. Turner, J. C. Gumbart, and E. Park. 2024. Substrate recognition mechanism of the Endoplasmic reticulum-associated ubiquitin ligase Doa10. Nature Communications 15:2182.","journal-title":"Nature Communications"},{"key":"2340_CR26","doi-asserted-by":"publisher","first-page":"159482","DOI":"10.1016\/j.bbalip.2024.159482","volume":"1869","author":"NM Fenton","year":"2024","unstructured":"Fenton, N. M., L. Qian, N. A. Scott, E. G. Paine, L. J. Sharpe, and A. J. Brown. 2024. SC5D is the sixth enzyme in cholesterol biosynthesis targeted by the E3 ubiquitin ligase MARCHF6. Biochim Biophys Acta Mol Cell Biol Lipids 1869:159482.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2340_CR27","doi-asserted-by":"publisher","first-page":"100362","DOI":"10.1016\/j.jlr.2023.100362","volume":"64","author":"L Qian","year":"2023","unstructured":"Qian, L., N. A. Scott, I. M. Capell-Hattam, E. A. Draper, N. M. Fenton, W. Luu, L. J. Sharpe, and A. J. Brown. 2023. Cholesterol synthesis enzyme SC4MOL is fine-tuned by sterols and targeted for degradation by the E3 ligase MARCHF6. Journal of Lipid Research 64:100362.","journal-title":"Journal of Lipid Research"},{"key":"2340_CR28","doi-asserted-by":"publisher","first-page":"158837","DOI":"10.1016\/j.bbalip.2020.158837","volume":"1866","author":"NA Scott","year":"2021","unstructured":"Scott, N. A., L. J. Sharpe, and A. J. Brown. 2021. The E3 ubiquitin ligase MARCHF6 as a metabolic integrator in cholesterol synthesis and beyond. Biochim Biophys Acta Mol Cell Biol Lipids 1866:158837.","journal-title":"Biochim Biophys Acta Mol Cell Biol Lipids"},{"key":"2340_CR29","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1128\/MCB.01140-13","volume":"34","author":"N Zelcer","year":"2014","unstructured":"Zelcer, N., L. J. Sharpe, A. Loregger, I. Kristiana, E. C. Cook, L. Phan, J. Stevenson, and A. J. Brown. 2014. The E3 ubiquitin ligase MARCH6 degrades squalene monooxygenase and affects 3-hydroxy-3-methyl-glutaryl coenzyme A reductase and the cholesterol synthesis pathway. Molecular and Cellular Biology 34:1262\u20131270.","journal-title":"Molecular and Cellular Biology"},{"key":"2340_CR30","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1038\/s41556-022-00973-1","volume":"24","author":"KT Nguyen","year":"2022","unstructured":"Nguyen, K. T., S. H. Mun, J. Yang, J. Lee, O. H. Seok, E. Kim, D. Kim, S. Y. An, D. Y. Seo, and J. Y. Suh et al. 2022. The MARCHF6 E3 ubiquitin ligase acts as an NADPH sensor for the regulation of ferroptosis. Nature Cell Biology 24:1239\u20131251.","journal-title":"Nature Cell Biology"},{"key":"2340_CR31","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1186\/s12967-022-03658-3","volume":"20","author":"G Kuang","year":"2022","unstructured":"Kuang, G., W. Wang, D. Xiong, and C. Zeng. 2022. An NADPH sensor that regulates cell ferroptosis. J Transl Med 20:474.","journal-title":"J Transl Med"},{"key":"2340_CR32","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1016\/j.tcb.2023.07.003","volume":"33","author":"J Yang","year":"2023","unstructured":"Yang, J., Y. Lee, and C. S. Hwang. 2023. The ubiquitin-proteasome system links NADPH metabolism to ferroptosis. Trends in Cell Biology 33:1088\u20131103.","journal-title":"Trends in Cell Biology"},{"key":"2340_CR33","doi-asserted-by":"publisher","first-page":"107731","DOI":"10.1016\/j.jbc.2024.107731","volume":"300","author":"J Yang","year":"2024","unstructured":"Yang, J., S. Y. Kim, and C. S. Hwang. 2024. Delineation of the substrate recognition domain of MARCHF6 E3 ubiquitin ligase in the Ac\/N-degron pathway and its regulatory role in ferroptosis. Journal of Biological Chemistry 300:107731.","journal-title":"Journal of Biological Chemistry"},{"key":"2340_CR34","doi-asserted-by":"publisher","first-page":"112746","DOI":"10.1016\/j.celrep.2023.112746","volume":"42","author":"SH Mun","year":"2023","unstructured":"Mun, S. H., C. S. Lee, H. J. Kim, J. Kim, H. Lee, J. Yang, S. H. Im, J. H. Kim, J. K. Seong, and C. S. Hwang. 2023. Marchf6 E3 ubiquitin ligase critically regulates Endoplasmic reticulum stress, ferroptosis, and metabolic homeostasis in POMC neurons. Cell Rep 42:112746.","journal-title":"Cell Rep"},{"key":"2340_CR35","doi-asserted-by":"publisher","first-page":"100008","DOI":"10.1016\/j.mocell.2024.100008","volume":"47","author":"SH Mun","year":"2024","unstructured":"Mun, S. H., and C. S. Hwang. 2024. Marchf6: A guardian against cytosol-spilled POMC-induced ferroptosis. Molecules and Cells 47:100008.","journal-title":"Molecules and Cells"},{"key":"2340_CR36","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1007\/s00395-024-01073-x","volume":"119","author":"DA Duse","year":"2024","unstructured":"Duse, D. A., N. H. Schroder, T. Srivastava, M. Benkhoff, J. Vogt, M. K. Nowak, F. Funk, N. Semleit, P. Wollnitzke, and R. Erkens et al. 2024. Deficiency of the sphingosine-1-phosphate (S1P) transporter Mfsd2b protects the heart against hypertension-induced cardiac remodeling by suppressing the L-type-Ca(2+) channel. Basic Research in Cardiology 119:853\u2013868.","journal-title":"Basic Research in Cardiology"},{"key":"2340_CR37","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00395-016-0536-7","volume":"111","author":"CY Li","year":"2016","unstructured":"Li, C. Y., Q. Zhou, L. C. Yang, Y. H. Chen, J. W. Hou, K. Guo, Y. P. Wang, and Y. G. Li. 2016. Dual-specificity phosphatase 14 protects the heart from aortic banding-induced cardiac hypertrophy and dysfunction through inactivation of TAK1-P38MAPK\/-JNK1\/2 signaling pathway. Basic Research in Cardiology 111:19.","journal-title":"Basic Research in Cardiology"},{"key":"2340_CR38","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1042\/BJ20041241","volume":"388","author":"G Hassink","year":"2005","unstructured":"Hassink, G., M. Kikkert, S. van Voorden, S. J. Lee, R. Spaapen, T. van Laar, C. S. Coleman, E. Bartee, K. Fruh, and V. Chau et al. 2005. TEB4 is a C4HC3 RING finger-containing ubiquitin ligase of the Endoplasmic reticulum. The Biochemical Journal 388:647\u2013655.","journal-title":"The Biochemical Journal"},{"key":"2340_CR39","doi-asserted-by":"publisher","first-page":"107944","DOI":"10.1016\/j.celrep.2020.107944","volume":"32","author":"JME Tan","year":"2020","unstructured":"Tan, J. M. E., M. M. van der Stoel, M. van den Berg, N. M. van Loon, M. Moeton, E. Scholl, N. N. van der Wel, I. Kovacevic, P. L. Hordijk, and A. Loregger et al. 2020. The MARCH6-SQLE Axis controls endothelial cholesterol homeostasis and angiogenic sprouting. Cell Rep 32:107944.","journal-title":"Cell Rep"},{"key":"2340_CR40","doi-asserted-by":"publisher","first-page":"4919","DOI":"10.1038\/s41467-019-12763-9","volume":"10","author":"RT Florian","year":"2019","unstructured":"Florian, R. T., F. Kraft, E. Leitao, S. Kaya, S. Klebe, E. Magnin, A. F. van Rootselaar, J. Buratti, T. Kuhnel, and C. Schroder et al. 2019. Unstable TTTTA\/TTTCA expansions in MARCH6 are associated with Familial adult myoclonic epilepsy type 3. Nature Communications 10:4919.","journal-title":"Nature Communications"},{"key":"2340_CR41","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1186\/s12885-021-08540-x","volume":"21","author":"J Sun","year":"2021","unstructured":"Sun, J., Z. Dong, Z. Chang, H. Liu, Q. Jiang, D. Zhang, S. Lu, X. Jia, D. Wu, and A. Ge et al. 2021. MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2. Bmc Cancer 21:827.","journal-title":"Bmc Cancer"},{"key":"2340_CR42","doi-asserted-by":"publisher","first-page":"3401","DOI":"10.7150\/ijbs.60628","volume":"17","author":"Y Liu","year":"2021","unstructured":"Liu, Y., S. Xu, Y. Huang, S. Liu, Z. Xu, M. Wei, and J. Liu. 2021. MARCH6 promotes papillary thyroid Cancer development by destabilizing DHX9. International Journal of Biological Sciences 17:3401\u20133412.","journal-title":"International Journal of Biological Sciences"},{"key":"2340_CR43","doi-asserted-by":"publisher","DOI":"10.1007\/s11302-11024-10048-11305","author":"AS Shatat","year":"2025","unstructured":"Shatat, A. S. 2025. The P2X(7)R is a crucial target for Angiotensin II-induced myocardial ferroptosis and remodeling. Purinergic Signal 21:385\u2013388.\u00a0https:\/\/doi.org\/10.1007\/s11302-11024-10048-11305","journal-title":"Purinergic Signal"},{"key":"2340_CR44","doi-asserted-by":"publisher","first-page":"267","DOI":"10.31083\/j.fbl2907267","volume":"29","author":"C Wang","year":"2024","unstructured":"Wang, C., C. Chen, J. Zhou, J. Shi, H. Sun, J. Li, P. Gu, X. Wang, Q. Lu, and S. Wang. 2024. DHODH alleviates heart failure via the modulation of CoQ-Related ferroptotic Inhibition. Front Biosci (Landmark Ed) 29:267.","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2340_CR45","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s10020-024-00783-1","volume":"30","author":"H Yu","year":"2024","unstructured":"Yu, H., D. Gan, Z. Luo, Q. Yang, D. An, H. Zhang, Y. Hu, Z. Ma, Q. Zeng, and D. Xu et al. 2024. alpha-Ketoglutarate improves cardiac insufficiency through NAD(+)-SIRT1 signaling-mediated mitophagy and ferroptosis in pressure overload-induced mice. Molecular Medicine 30:15.","journal-title":"Molecular Medicine"},{"key":"2340_CR46","doi-asserted-by":"publisher","first-page":"2162537","DOI":"10.1080\/10641963.2022.2162537","volume":"45","author":"S Li","year":"2023","unstructured":"Li, S., P. Wen, D. Zhang, D. Li, Q. Gao, H. Liu, and Y. Di. 2023. PGAM5 expression levels in heart failure and protection ROS-induced oxidative stress and ferroptosis by Keap1\/Nrf2. Clinical and Experimental Hypertension 45:2162537.","journal-title":"Clinical and Experimental Hypertension"},{"key":"2340_CR47","doi-asserted-by":"publisher","first-page":"103154","DOI":"10.1016\/j.redox.2024.103154","volume":"72","author":"X Zhong","year":"2024","unstructured":"Zhong, X., K. Wang, Y. Wang, L. Wang, S. Wang, W. Huang, Z. Jia, S. S. Dai, and Z. Huang. 2024. Angiotension II directly bind P2X7 receptor to induce myocardial ferroptosis and remodeling by activating human antigen R. Redox Biology 72:103154.","journal-title":"Redox Biology"},{"key":"2340_CR48","doi-asserted-by":"publisher","first-page":"110974","DOI":"10.1016\/j.cellsig.2023.110974","volume":"113","author":"C Lv","year":"2024","unstructured":"Lv, C., L. Zhou, Y. Meng, H. Yuan, and J. Geng. 2024. PKD knockdown mitigates Ang II-induced cardiac hypertrophy and ferroptosis via the JNK\/P53 signaling pathway. Cellular Signalling 113:110974.","journal-title":"Cellular Signalling"},{"key":"2340_CR49","doi-asserted-by":"publisher","first-page":"103597","DOI":"10.1016\/j.redox.2025.103597","volume":"82","author":"G She","year":"2025","unstructured":"She, G., X. X. Hai, L. Y. Jia, Y. J. Zhang, Y. J. Ren, Z. D. Pang, L. H. Wu, M. Z. Han, Y. Zhang, and J. J. Li et al. 2025. Hippo pathway activation mediates cardiomyocyte ferroptosis to promote dilated cardiomyopathy through downregulating NFS1. Redox Biology 82:103597.","journal-title":"Redox Biology"},{"key":"2340_CR50","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.freeradbiomed.2022.01.020","volume":"181","author":"Z Zhang","year":"2022","unstructured":"Zhang, Z., J. Tang, J. Song, M. Xie, Y. Liu, Z. Dong, X. Liu, X. Li, M. Zhang, and Y. Chen et al. 2022. Elabela alleviates ferroptosis, myocardial remodeling, fibrosis and heart dysfunction in hypertensive mice by modulating the IL-6\/STAT3\/GPX4 signaling. Free Radical Biology and Medicine 181:130\u2013142.","journal-title":"Free Radical Biology and Medicine"},{"key":"2340_CR51","doi-asserted-by":"publisher","first-page":"1450656","DOI":"10.3389\/fphys.2024.1450656","volume":"15","author":"S Fatima","year":"2024","unstructured":"Fatima, S., H. Zhou, Y. Chen, and Q. Liu. 2024. Role of ferroptosis in the pathogenesis of heart disease. Frontiers in Physiology 15:1450656.","journal-title":"Frontiers in Physiology"},{"key":"2340_CR52","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1038\/nchembio.2239","volume":"13","author":"S Doll","year":"2017","unstructured":"Doll, S., B. Proneth, Y. Y. Tyurina, E. Panzilius, S. Kobayashi, I. Ingold, M. Irmler, J. Beckers, M. Aichler, and A. Walch et al. 2017. ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition. Nature Chemical Biology 13:91\u201398.","journal-title":"Nature Chemical Biology"},{"key":"2340_CR53","doi-asserted-by":"publisher","first-page":"1054","DOI":"10.1038\/s41440-024-02068-w","volume":"48","author":"X Han","year":"2025","unstructured":"Han, X., Q. Q. Zhu, Z. Li, J. K. He, Y. Sun, Q. H. Zhong, S. X. Tang, and Y. L. Zhang. 2025. 4-Hydroxychalcone attenuates AngII-induced cardiac remodeling and dysfunction via regulating PI3K\/AKT pathway. Hypertension Research 48:1054\u20131067.","journal-title":"Hypertension Research"},{"key":"2340_CR54","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/s00018-023-04909-2","volume":"80","author":"J Xie","year":"2023","unstructured":"Xie, J., C. Zheng, M. Shen, W. Lu, M. Li, M. He, L. Chen, S. Ma, Y. Zhu, and H. Lin et al. 2023. Pregnancy-induced physiological hypertrophic preconditioning attenuates pathological myocardial hypertrophy by activation of FoxO3a. Cellular and Molecular Life Sciences 80:267.","journal-title":"Cellular and Molecular Life Sciences"},{"key":"2340_CR55","doi-asserted-by":"publisher","first-page":"111650","DOI":"10.1016\/j.cellsig.2025.111650","volume":"130","author":"L Ge","year":"2025","unstructured":"Ge, L., J. Ma, J. Xu, B. Wang, A. Adil, and H. Xu. 2025. The mechanism of LncRNA PVT1 targeting the miR-30a\/Beclin-1 axis to mediate ventricular remodeling in spontaneously hypertensive rats. Cellular Signalling 130:111650.","journal-title":"Cellular Signalling"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02340-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-025-02340-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-025-02340-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T14:02:26Z","timestamp":1766412146000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-025-02340-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":55,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2340"],"URL":"https:\/\/doi.org\/10.1007\/s10753-025-02340-2","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"20 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 July 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was obtained from the Institutional Animal Care and Use Committee of Central Hospital Affiliated to Shandong First Medical University. All experimental procedures were conducted in accordance with the National Institutes of Health guidelines for the care and use of laboratory animals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval and Consent to Participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Clinical Trial Number"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}